Erhun

Hyperbaric oxygen therapy (HBOT) for ME/CFS: Yes, No, Maybe?

Hyperbaric oxygen therapy (HBOT) is a medical treatment where patients breathe pure oxygen inside a pressurised chamber. The higher-than-normal pressure…

Orexins and GLP-1s as they relate to long COVID and ME/CFS

A recent review highlighted the devastating multi-system effects of COVID on the body, particularly emphasising the endocrinological (hormonal) consequences manifesting…

Featured Research

Molecular understanding of ME/CFS: Genetics

Genetics (the study of segments of DNA called genes) and epigenetics (how environmental and other factors impact gene activity) are becoming…

Featured Research

Pre-print – The case against deconditioning as the cause of ME/CFS

Last May, a team of researchers led by Braeden Charlton and including ME Research UK-funded researcher Associate Professor Rob Wüst…

Featured News Research

Post-Acute Vaccination Syndrome: International ME/CFS Conference 2026

ME Research UK attended remotely the International ME/CFS Conference 2026 – Understand, Diagnose, Treat (May 7-8th), hosted by Charité Fatigue Center,…

Featured News Research

ME Awareness Week 2026 – Recap

For ME Awareness Week 2026, we discussed ME/CFS symptoms, impact, and research. For ease of access, these are links to…

Featured News Research

ME Awareness Week 2026 – Overview

ME Awareness Week takes place every May during the week of May 12th, which marks International ME Awareness Day. The…

Featured News Research

GLP-1 receptor agonists for ME/CFS?

GLP-1 receptor agonists are currently licensed for the treatment of type 2 diabetes and for weight management in overweight/obese individuals.…

Featured Research

Hydrogen water in ME/CFS – helpful or not?

Hydrogen can be dissolved in water and consumed orally as a drink, with potential health benefits according to some sources.…

Featured Fundraising News

ME Research UK – e-newsletter March 2026

New funding award: Immune exhaustion in ME/CFS ME Research UK is delighted to have awarded funding to Dr Andrea Polli…